CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Harvard Bioscience - HBIO CFD

    5.8725
    5%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.0350
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Harvard Bioscience Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 5.5929
    开仓* 5.6628
    1 年变化* 51.41%
    日范围* 5.6628 - 5.9824
    52 周范围 1.98-6.29
    平均交易量（10 天） 213.48K
    平均交易量（3 个月) 4.01M
    市值 248.08M
    市盈率 -100.00K
    流通股 42.19M
    收入 114.53M
    EPS -0.05
    股息（收益率 %） N/A
    贝塔 1.68
    下一个财报发布日期 Aug 1, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    May 26, 2023 5.8725 0.3797 6.91% 5.4928 5.9824 5.4928
    May 25, 2023 5.5929 0.1400 2.57% 5.4529 5.6028 5.3631
    May 24, 2023 5.6728 0.0401 0.71% 5.6327 5.7227 5.3631
    May 23, 2023 5.6728 -0.1897 -3.24% 5.8625 5.9125 5.6328
    May 22, 2023 5.8625 0.1799 3.17% 5.6826 5.9025 5.6826
    May 19, 2023 5.7427 0.2098 3.79% 5.5329 5.9424 5.4630
    May 18, 2023 5.5629 -0.0599 -1.07% 5.6228 5.6228 5.4131
    May 17, 2023 5.6228 0.2598 4.84% 5.3630 5.6628 5.3630
    May 16, 2023 5.4131 0.3197 6.28% 5.0934 5.4730 5.0934
    May 15, 2023 5.3232 -0.2995 -5.33% 5.6227 5.6228 5.0835
    May 12, 2023 5.5829 -0.1398 -2.44% 5.7227 5.8326 5.4930
    May 11, 2023 5.7127 0.3197 5.93% 5.3930 5.7427 5.3731
    May 10, 2023 5.5829 -0.1397 -2.44% 5.7226 5.8226 5.5130
    May 9, 2023 5.7127 -0.0598 -1.04% 5.7725 5.8026 5.3431
    May 8, 2023 5.8825 -0.2597 -4.23% 6.1422 6.2021 5.8225
    May 5, 2023 6.1222 -0.0599 -0.97% 6.1821 6.1821 6.0023
    May 4, 2023 6.1122 0.1099 1.83% 6.0023 6.2321 5.9923
    May 3, 2023 6.0922 -0.0500 -0.81% 6.1422 6.1422 5.8025
    May 2, 2023 6.0623 0.1699 2.88% 5.8924 6.2520 5.7126
    May 1, 2023 5.9325 0.3198 5.70% 5.6127 6.0723 5.6127

    Harvard Bioscience Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Tuesday, August 1, 2023

    时间（协调世界时） (UTC)

    20:00

    国家/地区

    US

    事件

    Q2 2023 Harvard Bioscience Inc Earnings Release
    Q2 2023 Harvard Bioscience Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q3 2023 Harvard Bioscience Inc Earnings Release
    Q3 2023 Harvard Bioscience Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 113.335 118.904 102.1 116.176 120.774
    收入 113.335 118.904 102.1 116.176 120.774
    收入成本，共计 51.045 51.252 44.059 51.654 53.793
    毛利 62.29 67.652 58.041 64.522 66.981
    总营业费用 120.268 116.838 103.755 115.799 123.19
    销售/一般/行政费用，总计 48.611 47.672 43.425 45.324 45.825
    研究与开发 12.329 10.799 8.685 10.715 10.988
    Depreciation / Amortization 6.122 5.84 5.71 5.746 5.384
    异常费用（收入） 2.161 1.275 1.876 2.36 7.2
    营业收入 -6.933 2.066 -1.655 0.377 -2.416
    利息收入（费用），非经营净值 -2.548 -1.54 -4.831 -5.41 -5.219
    其他，净值 0.302 -0.666 -0.806 -0.469 -0.34
    税前净收入 -9.179 -0.14 -7.292 -5.502 -7.975
    税后净收入 -9.516 -0.288 -7.81 -4.687 -4.299
    未计算非常项目前的净收益 -9.516 -0.288 -7.81 -4.687 -4.299
    净收入 -9.516 -0.288 -7.81 -4.687 -2.922
    普通股股东可获收益 (不含非经常性项目) -9.516 -0.288 -7.81 -4.687 -4.299
    普通股股东可获收益 (含非經常性項目) -9.516 -0.288 -7.81 -4.687 -2.922
    摊薄净收入 -9.516 -0.288 -7.81 -4.687 -2.922
    摊薄后加权平均股 41.413 40.343 38.64 37.814 36.453
    扣除特别项目的每股摊薄盈利 -0.22978 -0.00714 -0.20212 -0.12395 -0.11793
    每股正常摊薄盈利 -0.19586 0.0134 -0.13637 -0.08338 0.01045
    非常规项目总计 0 1.377
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 29.975 28.427 26.922 29.208 28.778
    收入 29.975 28.427 26.922 29.208 28.778
    收入成本，共计 11.629 12.594 14.75 12.571 12.601
    毛利 18.346 15.833 12.172 16.637 16.177
    总营业费用 28.226 28.884 30.684 25.21 35.49
    销售/一般/行政费用，总计 12.312 11.811 12.143 12.568 13.012
    研究与开发 2.897 2.849 2.763 3.497 3.22
    Depreciation / Amortization 1.388 1.63 1.572 1.454 1.466
    异常费用（收入） 0 0 -0.544 -4.88 5.191
    营业收入 1.749 -0.457 -3.762 3.998 -6.712
    利息收入（费用），非经营净值 -0.974 -0.9 -0.749 -0.515 -0.384
    其他，净值 0.432 0.465 -0.179 -0.062 0.078
    税前净收入 1.207 -0.892 -4.69 3.421 -7.018
    税后净收入 0.622 -1.666 -3.405 2.435 -6.88
    未计算非常项目前的净收益 0.622 -1.666 -3.405 2.435 -6.88
    净收入 0.622 -1.666 -3.405 2.435 -6.88
    普通股股东可获收益 (不含非经常性项目) 0.622 -1.666 -3.405 2.435 -6.88
    普通股股东可获收益 (含非經常性項目) 0.622 -1.666 -3.405 2.435 -6.88
    摊薄净收入 0.622 -1.666 -3.405 2.435 -6.88
    摊薄后加权平均股 42.783 41.593 41.637 42.56 41.219
    扣除特别项目的每股摊薄盈利 0.01454 -0.04005 -0.08178 0.05721 -0.16691
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 0.01454 -0.04005 -0.09027 -0.01732 -0.08505
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 51.124 61.583 51.7 53.572 57.832
    现金和短期投资 4.508 7.821 8.317 8.335 8.173
    现金等价物 4.508 7.821 8.317 8.335 8.173
    应收账款总额，净额 20.177 26.175 21.121 23.176 24.572
    Accounts Receivable - Trade, Net 16.705 21.834 17.766 20.704 21.463
    Total Inventory 26.439 27.587 22.262 22.061 25.087
    Other Current Assets, Total
    Total Assets 145.36 162.344 156.254 164.87 168.613
    Property/Plant/Equipment, Total - Net 9.182 10.312 11.721 13.239 5.898
    Property/Plant/Equipment, Total - Gross 24.028 24.761 28.318 28.179 23.336
    Accumulated Depreciation, Total -14.846 -14.449 -16.597 -14.94 -17.438
    Goodwill, Net 56.26 57.689 58.59 57.381 57.304
    Intangibles, Net 21.014 27.385 33.151 38.405 45.764
    Other Long Term Assets, Total 7.78 5.375 1.092 2.273 1.815
    Total Current Liabilities 23.249 25.316 21.053 25.312 25.489
    Accounts Payable 6.447 4.911 5.972 5.339 7.359
    Accrued Expenses 8.639 11.175 7.582 2.424 5.762
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 3.811 3.235 1.721 6.9 5.982
    Other Current Liabilities, Total 4.352 5.995 5.778 10.649 6.386
    Total Liabilities 73.14 78.943 79.573 83.176 85.889
    Total Long Term Debt 43.013 45.095 46.286 46.917 54.813
    Long Term Debt 43.013 45.095 46.286 46.917 54.813
    Deferred Income Tax 0.59 1.558 1.899 1.974 2.301
    Other Liabilities, Total 6.288 6.974 10.335 8.973 3.286
    Total Equity 72.22 83.401 76.681 81.694 82.724
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.454 0.452 0.444 0.438 0.436
    Additional Paid-In Capital 229.008 225.65 232.357 229.189 226.377
    Retained Earnings (Accumulated Deficit) -142.19 -132.674 -132.386 -124.576 -119.889
    Treasury Stock - Common 0 -10.668 -10.668 -10.668
    Other Equity, Total -15.052 -10.027 -13.066 -12.689 -13.532
    Total Liabilities & Shareholders’ Equity 145.36 162.344 156.254 164.87 168.613
    Total Common Shares Outstanding 42.0817 41.1429 39.4071 38.1882 37.3788
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 52.449 51.124 51.818 56.498 59.448
    现金和短期投资 3.789 4.508 5.144 4.259 5.433
    现金等价物 3.789 4.508 5.144 4.259 5.433
    应收账款总额，净额 21.799 20.177 20.558 22.903 25.304
    Accounts Receivable - Trade, Net 17.737 16.705 15.023 17.847 20.274
    Total Inventory 26.861 26.439 26.116 29.336 28.711
    Total Assets 145.578 145.36 147.013 155.273 158.044
    Property/Plant/Equipment, Total - Net 8.929 9.182 9.574 9.63 10.104
    Goodwill, Net 56.618 56.26 54.851 56.232 57.356
    Intangibles, Net 19.641 21.014 22.464 24.219 25.878
    Other Long Term Assets, Total 7.941 7.78 8.306 8.694 5.258
    Total Current Liabilities 23.217 23.249 21.36 23.354 27.226
    Accounts Payable 5.978 6.447 5.877 6.81 6.218
    Accrued Expenses 8.356 8.639 8.165 8.192 7.725
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 2.97 3.811 2.72 2.72 2.72
    Other Current Liabilities, Total 5.913 4.352 4.598 5.632 10.563
    Total Liabilities 71.238 73.14 75.034 77.769 81.669
    Total Long Term Debt 41.083 43.013 46.534 45.764 46.244
    Long Term Debt 41.083 43.013 46.534 45.764 46.244
    Deferred Income Tax 0.546 0.59 1.181 2.427 1.442
    Other Liabilities, Total 6.392 6.288 5.959 6.224 6.757
    Total Equity 74.34 72.22 71.979 77.504 76.375
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.455 0.454 0.453 0.453 0.452
    Additional Paid-In Capital 230.108 229.008 228.229 227.413 226.203
    Retained Earnings (Accumulated Deficit) -141.568 -142.19 -140.524 -137.119 -139.554
    Treasury Stock - Common
    Other Equity, Total -14.655 -15.052 -16.179 -13.243 -10.726
    Total Liabilities & Shareholders’ Equity 145.578 145.36 147.013 155.273 158.044
    Total Common Shares Outstanding 42.19 42.0817 41.6577 41.4997 41.2415
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -9.516 -0.288 -7.81 -4.687 -2.922
    经营活动产生的现金 1.152 1.262 9.331 8.045 2.884
    经营活动产生的现金 1.453 1.781 1.922 1.987 2.423
    Amortization 6.122 5.84 5.71 5.746 5.459
    Deferred Taxes -0.414 -0.33 -0.143 -0.398 -2.861
    非现金物品 0.791 4.449 5.546 5.355 2.46
    Cash Taxes Paid 0.534 0.577 0.416 0.374 -0.098
    已付现金利息 2.314 1.577 4.881 5.496 4.987
    营运资金的变化 2.716 -10.19 4.106 0.042 -1.675
    投资活动产生的现金 -1.59 -1.345 -1.402 -0.229 -53.796
    资本支出 -1.59 -1.345 -1.152 -1.216 -1.006
    其他投资现金流量项目，总计 -0.25 0.987 -52.79
    融资活动产生的现金 -2.837 -0.252 -7.967 -7.624 53.053
    股票的发行（报废），净额 0.577 3.314 4.557
    债务的发行（退还），净额 -1.786 0.05 -5.597 -7.403 48.496
    外汇效应 -0.038 -0.161 0.02 -0.03 0.299
    现金净变化 -3.313 -0.496 -0.018 0.162 2.44
    融资现金流项目 -1.628 -3.616 -2.37 -0.221
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 0.622 -9.516 -7.85 -4.445 -6.88
    Cash From Operating Activities 1.812 1.152 -1.527 -2.176 -1.986
    Cash From Operating Activities 0.333 1.453 1.122 0.758 0.382
    Amortization 1.388 6.122 4.492 2.92 1.466
    Non-Cash Items 0.765 0.791 -0.289 -1.498 0.97
    Cash Taxes Paid -0.134 0.534 0.493 0.352 0.107
    Cash Interest Paid 1.172 2.314 1.529 0.845 0.383
    Changes in Working Capital -1.296 2.716 1.158 -0.951 2.076
    Cash From Investing Activities 0.288 -1.59 -1.355 -0.913 -0.471
    Capital Expenditures -0.224 -1.59 -1.355 -0.913 -0.471
    Cash From Financing Activities -2.893 -2.837 -0.107 -0.484 0.094
    Financing Cash Flow Items -0.156 -1.628 -1.167 -0.78 -0.501
    Issuance (Retirement) of Stock, Net 0.104 0.577 0.346 0.282 0.031
    Issuance (Retirement) of Debt, Net -2.841 -1.786 0.714 0.014 0.564
    Foreign Exchange Effects 0.074 -0.038 0.312 0.011 -0.025
    Net Change in Cash -0.719 -3.313 -2.677 -3.562 -2.388
    Deferred Taxes -0.414 -0.16 1.04
    Other Investing Cash Flow Items, Total 0.512
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    B. Riley Asset Management, LLC Investment Advisor/Hedge Fund 8.0796 3408796 221500 2023-03-31 MED
    Punch & Associates Investment Management, Inc. Investment Advisor/Hedge Fund 6.9858 2947329 183290 2023-03-31
    Harvey Partners, LLC Hedge Fund 6.4297 2712700 -198800 2023-03-31
    AMH Equity, Ltd. Hedge Fund 4.8682 2053907 0 2023-03-31 MED
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 4.1364 1745133 3985 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.1337 1743996 486198 2023-03-31 LOW
    Green (James W) Individual Investor 3.6219 1528067 634619 2023-03-21 LOW
    Royce Investment Partners Investment Advisor/Hedge Fund 3.4112 1439182 14319 2023-03-31 LOW
    Granahan Investment Management, Inc. Investment Advisor 3.3898 1430151 -32306 2023-03-31 LOW
    Archon Capital Management LLC Hedge Fund 3.2277 1361769 0 2023-03-31
    Boothbay Fund Management, LLC Investment Advisor/Hedge Fund 2.9275 1235098 162269 2023-03-31 HIGH
    Heartland Advisors, Inc. Investment Advisor/Hedge Fund 2.8443 1200000 85601 2023-03-31
    Meros Investment Management, LP Investment Advisor 2.6646 1124206 -12639 2023-03-31
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 2.6197 1105253 0 2023-03-31 MED
    Portolan Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.4734 1043546 -10754 2023-03-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 2.0457 863075 -550 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 1.7303 730007 -4300 2023-03-31 HIGH
    Florida State Board of Administration Pension Fund 1.5231 642604 535604 2022-09-30 LOW
    Monarch Partners Asset Management LLC Investment Advisor/Hedge Fund 1.4549 613837 -187422 2022-12-31
    JP Morgan Asset Management Investment Advisor 1.2399 523120 0 2023-03-31 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    530K+

    交易者

    87K+

    每月活跃客户

    $46M+

    每月投资额

    $31M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Harvard Bioscience Company profile

    关于 Harvard Bioscience

    哈佛生物科学公司是一家技术、产品和服务的开发商、制造商和销售商，为药物开发的基础研究、发现和临床前测试提供支持。 公司提供的产品支持六种不同类别的实验室用途的研究，包括分子、细胞、组织、器官、生物体和临床。 公司主要以多个品牌销售其产品，包括Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, 和MCS。 公司的客户包括制药和生物技术公司，以及合同研究组织、学术实验室和政府研究人员。

    Industry: Advanced Medical Equipment & Technology (NEC)

    84 October Hill Rd
    HOLLISTON
    MASSACHUSETTS 01746-1371
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Oil - Crude

    73.27 Price
    +0.450% 1D Chg, %
    多头隔夜费 -0.0154%
    空头隔夜费 -0.0065%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    Gold

    1,945.16 Price
    -0.070% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0103%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    XRP/USD

    0.48 Price
    +0.570% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00369

    BTC/USD

    27,939.60 Price
    +1.210% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    还在找一位您可以信任的经纪商吗？

    加入成为全球530,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易